Results 11 to 20 of about 36,054 (205)
Human Papillomavirus Vaccines. [PDF]
J Infect Dis, 2021 Abstract Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so without specific induction of mucosal immunity.
Markowitz LE, Schiller JT.
europepmc +4 more sources
Reviews in Medical Virology, 2006 AbstractA wealth of epidemiological and molecular evidence has led to the conclusion that virtually all cases of cervical cancer and its precursor intra‐epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs) suggesting that prevention of infection by prophylactic vaccination would be an ...
Mia R, Schmiedeskamp, Denise R, Kockler
europepmc +6 more sources
Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study. [PDF]
Vaccines (Basel), 2023 Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as ...
Guimarães EL +13 more
europepmc +2 more sources
Human papillomavirus vaccines. [PDF]
CMAJ, 2017 Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70 ...
Ismail SJ, Deeks SL.
europepmc +4 more sources
Human Papillomavirus Vaccines: An Updated Review. [PDF]
Vaccines (Basel), 2020 Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated
Cheng L, Wang Y, Du J.
europepmc +2 more sources
Frontiers in Bioscience, 1998 The considerable morbidity and mortality associated with certain human papillomaviruses (HPV) has provided the impetus for HPV vaccine development. The design of such vaccines has evolved from an understanding of the nature of HPV infections and their consequences, together with evaluation of the efficacy of different approaches to vaccination in ...
Duggan-Keen, M +3 more
+7 more sources
Current status and future directions for the development of human papillomavirus vaccines [PDF]
Frontiers in ImmunologyLiangzhi Xie
exaly +2 more sources
Detection and genotyping of human Papillomavirus in urine samples from unvaccinated male and female adolescents in Italy [PDF]
, 2013 The introduction of vaccination against Human Papillomavirus (HPV) in adolescent girls in 2006 has focused virological surveillance on this age group. As few studies have evaluated HPV infections in young populations, further data are needed in order to ...
Zotti, CM +93 more
core +1 more source
Human Papillomavirus Vaccines and Vaccine Implementation [PDF]
Women's Health, 2008 Countries are now challenged by the rapid development of vaccines aimined at the primary prevention of infections. In the years to come, several vaccines will need to be considered as potential candidates in routine immunization programs. Recently, two new vaccines against two/four types of human papillomavirus (HPV) have been commercialized. Bivalent
Silvia, de Sanjosé +3 more
openaire +2 more sources